1. P922: HEALTH-RELATED QUALITY OF LIFE WITH TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC-1. (23rd June 2022) Authors: Popat, R.; Moreau, P.; Usmani, S. Z.; Garfall, A.; Mateos, M.-V.; San-Miguel, J. F.; Oriol, A.; Nooka, A. K.; Rosinol, L.; Chari, A.; Karlin, L.; Krishnan, A.; Bahlis, N.; Martin, T.; Besemer, B.; Martínez-López, J.; Delforge, M.; Fastenau, J.; Gries, K. S.; van de Donk, N. W. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 812 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗